Updated:
H1 Insights
H1 helps life sciences, pharma, health plans and digital health organizations identify key providers and prescribers, accelerate clinical trials, and advance...
H1 Insights
H1 helps life sciences, pharma, health plans and digital health organizations identify key providers and prescribers, accelerate clinical trials, and advance patient care everywhere.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
How does H1 Insights source and verify its physician data?
H1 aggregates healthcare professional data from public records, licensure boards, publication databases, and proprietary verifications, then structures it with AI to maintain an up-to-date global view of doctors, their affiliations, and their clinical and research experience.
Which business units at a pharmaceutical company typically use H1’s platform?
Clinical operations teams use H1 for trial site selection and patient recruitment; medical affairs teams apply it for thought-leader mapping and engagement; commercial teams leverage it for prescriber identification and targeting — all from the same underlying provider dataset.
Does H1 enable compliance with provider data regulations for health plans?
H1 markets a dedicated health plan solution that automates provider directory management to support accuracy across network rosters, member directories, and internal systems — addressing the operational burden of regulatory requirements like CMS audit standards.
What is H1’s geographic reach?
The platform claims customers across six continents and positions physician data as global rather than country-specific, though the firm’s marketing and testimonials are heavily anchored in major US healthcare markets.
How does H1 differ from a clinical trial-focused site intelligence tool?
H1 applies its provider database across clinical, medical, commercial, payer, and digital health workflows rather than specializing in one segment. This cross-enterprise design allows the same physician intelligence to serve trial recruitment, thought-leader engagement, and prescriber targeting under one subscription.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: